IBRX icon

ImmunityBio

62 hedge funds and large institutions have $43.5M invested in ImmunityBio in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

22% less capital invested

Capital invested by funds: $56.1M → $43.5M (-$12.6M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$117K
Puts
$14K
Net Calls
Net Calls Change

Top Buyers

1 +$489K
2 +$392K
3 +$345K
4
Renaissance Technologies
Renaissance Technologies
New York
+$270K
5
VF
Virtu Financial
New York
+$180K

Top Sellers

1 -$4.04M
2 -$1.01M
3 -$982K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$694K
5
BlackRock
BlackRock
New York
-$491K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.4M
2
$10.1M
3
$6.46M
4
$2.17M
5
$1.56M
6
$1.45M
7
$1.19M
8
$1.18M
9
$1.12M
10
$896K
11
$767K
12
$610K
13
$471K
14
$459K
15
$414K
16
$371K
17
$348K
18
$345K
19
$236K
20
$233K
21
$218K
22
$181K
23
$180K
24
$179K
25
$178K